Author  
Place of duty  
Title   ±ÙÄ¡Àû À§ÀýÁ¦¼úÀ» ½ÃÇàÇÑ 3 ±â À§¾ÏÀÇ Á¶±â Àç¹ß¿¹¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû ( A Clinical Study of Early Recurrence after Curative Gastric Resection for Stage 3 Stomach Cancer )
Publicationinfo   1994 Jan; 026(02): 188-198.
Key_word   Stomach Cancer, Early recurrence
Full-Text  
Abstract   69 cases of early recurred stomach cancer within 2 years from the point of initial curative gastric resection among the 211 cases of stage III stomach cancer have been analysed with regard to factors influencing early recurrence, which were operated at the Department of General Surgery, Kyung Hee Medical Center from January 1988 to April 1991. The results were as follows; 1) Curative gastric resection was performed in 211 cases and 69 cases(32.7%) of them were recurred within 2 years. 2) In 69 cases, the most frequent age group was under 30 years of age(50%), but that was not statistically significant, and male to female ratio was 5.9: 1. 3) The most common site of recurrence was peritoneum(40.5%), and the next was distant me- tastasis such as bone and lung(23.1%), liver(l4.5%), lymph nodes(8.6%), peritoneum and liver(7.2 %), remnant stomach(5.8%), in order of frequency. 4) The larger size of tumor, the higher early recurrence rate, but that was not statistically signif icant(p > 0.05). 5) The early recurrence rate was higher in antral lesion(p<0.05). 6) The early recurrence rate was higher in Borrmann type III and IV(p < 0.05). 7) When the distance of proximal & distal resection margin were shorter than 5 cm or 2 cm, the early recurrence rate was higher(p<0.005). 8) The early recurrence rate was higher in T, and T, lesion for the depth of invasion(p< 0.005). 9) The larger number of involved lymph nodes, the higher early recurrence rate(p<0.005), and that of R operation only was higher than R+a operation(p<0.05). 10). The early recurrence rate was higher in well differentiated tubular adenacarcinoma, but was not sigmificant(p>0.05). 1 1) The early recurrence rate was higher in under 3 cycles of postoperative adjuvant chemo- therapy(FAM) than in over 3 cycles(p<0.05).
Àú ÀÚ   ±è±âÁØ(Gi Jun Kim),ÀÌż®(Tae Seok Lee),¹Úȣö(Ho Chul Park),À±Ãæ(Choong Yoon)